TL-925 Ophthalmic Emulsion

TL-925 ophthalmic emulsion · Telios Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TL-925 Ophthalmic Emulsion, covering 2024-07-10 to 2024-07-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TL-925 Ophthalmic Emulsion as a Treatment for Dry Eye Disease [Phase 2]